Paul Carlson

Paul Carlson

Company: FDA

Job title: Principal Investigator


Regulatory Considerations for Microbiome Based Therapeutics 5:25 pm

Investigational New Drug Applications (INDs) Additional Chemistry, Manufacturing and Controls (CMC) considerations for INDs with: Fecal Microbiota Transplantation (FMT) Live Biotherapeutic Products (LBPs) COVID testing for FMT donorsRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.